These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 337095)

  • 21. L-asparaginase therapy in children with advanced leukemia. The Southwest Cancer Chemotherapy Study Group.
    Sutow WW; Garcia F; Starling KA; Williams TE; Lane DM; Gehan EA
    Cancer; 1971 Oct; 28(4):819-24. PubMed ID: 5286444
    [No Abstract]   [Full Text] [Related]  

  • 22. [Treatment of acute leukemias with L-asparaginase. Preliminary results].
    Jacquillat C; Weil M; Brunel-Kotschi R; Gemon MF; Levy D; Larrieu MJ; Bussel A; Tanzer J; Boiron M; Bernard J
    Med Welt; 1971 Mar; 13():503-8. PubMed ID: 5284282
    [No Abstract]   [Full Text] [Related]  

  • 23. Study of cytosine arabinoside (NSC-63878) synchronization plus vincristine (NSC-67574), prednisone (NSC-10023), and L-asparaginase (NSC-109229) for remission induction in advanced acute leukemia in children.
    Sutow WW; Thomas D; Steuber CP; Pullen J; Vats T; Bryan JH; Morgan SK
    Cancer Treat Rep; 1976 May; 60(5):591-4. PubMed ID: 991148
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Erwinia carotovora asparaginase in patients with prior anaphylaxis to asparaginase from E. coli.
    Ohnuma T; Holland JF; Meyer P
    Cancer; 1972 Aug; 30(2):376-81. PubMed ID: 4559405
    [No Abstract]   [Full Text] [Related]  

  • 25. L-Asparaginase as a single agent in acute lymphocytic leukemia: survey of studies form Childrens Cancer Study Group.
    Nesbit ME; Ertel I; Hammond GD
    Cancer Treat Rep; 1981; 65 Suppl 4():101-7. PubMed ID: 7049373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Refractory leukemia treated with cytosine arabinoside and cyclophosphamide.
    Ansari BM; Thompson EN
    Cancer; 1973 Aug; 32(2):294-7. PubMed ID: 4516215
    [No Abstract]   [Full Text] [Related]  

  • 27. [L-Asparaginase in the treatment of acute leukemia].
    Mathé G; Amiel JL; Clarysse A; Hayat M; Schwarzenberg L; Schneider M
    Sem Hop; 1970 Apr; 46(17):1135-40. PubMed ID: 4315231
    [No Abstract]   [Full Text] [Related]  

  • 28. [Therapeutic results and prognostic factors in acute lymphatic leukemia in the adult].
    Cavalli F; Hartmann H; Tschopp L; Sauter C; Alberto P
    Schweiz Med Wochenschr; 1977 Oct; 107(39):1361-6. PubMed ID: 269498
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Toxicity of L-asparginase in children with advanced leukemia.
    Land VJ; Sutow WW; Fernbach DJ; Lane DM; Williams TE
    Cancer; 1972 Aug; 30(2):339-47. PubMed ID: 4626307
    [No Abstract]   [Full Text] [Related]  

  • 30. Transient secondary hypothyroidism and thyroxine binding globulin deficiency in leukemic children during polychemotherapy: an effect of L-asparaginase.
    Heidemann PH; Stubbe P; Beck W
    Eur J Pediatr; 1981 Jul; 136(3):291-5. PubMed ID: 6167443
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparison of daily and twice-weekly schedule of L-asparaginase in childhood leukemia.
    Jaffe N; Traggis D; Das L; Kim BS; Won H; Hann L; Moloney WC; Dohlwitz A
    Pediatrics; 1972 Apr; 49(4):590-5. PubMed ID: 4501679
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparison of CNS-leukaemia in children with acute leukaemia, induced either with rubidomycin or L-asparaginase.
    de Vaan GA; Marcar JR; Schretlen ED
    Padiatr Padol; 1971; 6(3):230-9. PubMed ID: 5293526
    [No Abstract]   [Full Text] [Related]  

  • 33. Induction of remission with l-Asparaginase, cyclophosphamide, cytosine arabinoside, and prednisolone in adult patients with acute leukemia.
    Gahrton G; Engstedt L; Franzén S; Gullbring B; Holm G; Höglund S; Killander A; Killander D; Lockner D; Mellstedt H; Palmblad J; Reizenstein P; Skarberg KO; Swedberg B; Udén AM
    Cancer; 1974 Aug; 34(2):472-9. PubMed ID: 4527847
    [No Abstract]   [Full Text] [Related]  

  • 34. Use of L-asparaginase and cytosine arabinoside for refractory acute lymphocytic leukemia with particular reference to T-cell leukemia.
    Steuber CP; Levy GJ; Nix WL; Shepherd DA; Starling KA; Fernbach DJ
    Med Pediatr Oncol; 1978; 5(1):33-8. PubMed ID: 311413
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Treatment of acute lymphoblastic leukemia].
    Paolucci G; Rosito P
    Minerva Pediatr; 1971 Nov; 23(44):1851-69. PubMed ID: 4950250
    [No Abstract]   [Full Text] [Related]  

  • 36. Asparaginase in combination chemotherapy for remission induction of childhood acute lymphocytic leukemia.
    Pratt CB; Roberts D; Shanks E; Warmath EL; Jackson R
    Cancer Res; 1973 Sep; 33(9):2020-5. PubMed ID: 4516498
    [No Abstract]   [Full Text] [Related]  

  • 37. Asparaginase and amino acids in cancer therapeutics. Cancer and Leukemia Group B Investigators.
    Holland JF; Ohnuma T
    Cancer Treat Rep; 1981; 65 Suppl 4():123-30. PubMed ID: 7049376
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemotherapy of acute lymphocytic leukemia of childhood.
    Holland JF; Glidewell O
    Cancer; 1972 Dec; 30(6):1480-7. PubMed ID: 4509104
    [No Abstract]   [Full Text] [Related]  

  • 39. [Acute diabetic metabolic disorders during therapy of lymphoblastic leukemias].
    Kegel J; Gadner H; Riehm H; Weber B
    Monatsschr Kinderheilkd (1902); 1974 Jul; 122(7):694-5. PubMed ID: 4528132
    [No Abstract]   [Full Text] [Related]  

  • 40. L-asparaginase-induced coagulopathy in children with acute lymphoblastic leukaemia.
    Miniero R; Saracco P; Einaudi S; Garofalo F; Lange MM; Madon E
    Drugs Exp Clin Res; 1987; 13(6):377-9. PubMed ID: 3477418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.